logo
Search…
home
TOP News
Latest
RecommendHK StockUS StockChina StockMacroBond
Commercial
GlobalInvestment&FinancingCompany&ProductsCharacterESG
Economy&politics
Hong KongChinaAmerica
Stocks
HK StockChina StockUS Stock
Markets
HK StockUS Stock
IPO
Hong KongAmericaChina
Research
US StockHK Stock
Opinion
Recommendation
home
TOP News
Latest
RecommendHK StockUS StockChina StockMacroBond
Commercial
GlobalInvestment&FinancingCompany&ProductsCharacterESG
Economy&politics
Hong KongChinaAmerica
Stocks
HK StockChina StockUS Stock
Markets
HK StockUS Stock
IPO
Hong KongAmericaChina
Research
US StockHK Stock
Opinion
Recommendation
Search...
search
home
TOP News
Latest
RecommendHK StockUS StockChina StockMacroBond
Commercial
GlobalInvestment&FinancingCompany&ProductsCharacterESG
Economy&politics
Hong KongChinaAmerica
Stocks
HK StockChina StockUS Stock
Markets
HK StockUS Stock
IPO
Hong KongAmericaChina
Research
US StockHK Stock
Opinion
Recommendation
Home > Stocks > HK Stock

SINOPEC SEG (02386) will distribute an interim dividend of 0.127 yuan per share on October 30.

date
18:36 16/08/2026
avatar
GMT Eight
Sinopec Engineering (02386) announced that it will distribute an interim dividend of RMB 0.127 per share for the six months ending June 30, 2026, on October 30, 2026.
SINOPEC SEG (02386) announced that the company will distribute a mid-term dividend of RMB 0.127 per share for the six months ended June 30, 2026, on October 30, 2026.
Related Articles
HK Stock
SIMCERE PHARMA (02096) invested HKD 10.7033 million to repurchase 929,000 shares, demonstrating the company's confidence in its long-term development.
HK Stock
CLOUDBREAK-B (02592) will be suspended from trading starting the morning of September 10.
HK Stock
INSILICO (03696): The company's leading AI-driven candidate innovative drug Rentosertib has completed the enrollment of its first patient in a Phase III clinical trial for idiopathic pulmonary fibrosis.
SIMCERE PHARMA (02096) invested HKD 10.7033 million to repurchase 929,000 shares, demonstrating the company's confidence in its long-term development.
HK Stock
CLOUDBREAK-B (02592) will be suspended from trading starting the morning of September 10.
HK Stock
INSILICO (03696): The company's leading AI-driven candidate innovative drug Rentosertib has completed the enrollment of its first patient in a Phase III clinical trial for idiopathic pulmonary fibrosis.
HK Stock
RECOMMEND
Hot A‑Share Stocks Clarify Physical AI, Robotics, Aerospace, and Duty‑Free Themes Amid Frenzied Trading
Hot A‑Share Stocks Clarify Physical AI, Robotics, Aerospace, and Duty‑Free Themes Amid Frenzied Trading
icon
10/06/2026
U.S. AI Trading Frenzy Collapses as Jobs Data Fuels Fed Hike Fears
U.S. AI Trading Frenzy Collapses as Jobs Data Fuels Fed Hike Fears
icon
10/06/2026
Goldman Sachs Warns of AI‑Driven Market Heat, But Bubble Indicators Still Below Historical Extremes
Goldman Sachs Warns of AI‑Driven Market Heat, But Bubble Indicators Still Below Historical Extremes
icon
10/06/2026
logo
Contact US
qr
+852 - 60190728
gmteight@futurecultural.com
Customer Support
About Us
Contact Us
Frequently Asked
Privacy Policy
Terms of Use
Commercial Services
Advertising
Business Development
Copyright
Terms of Service
©️2013 - 2026 GMT EIGHT Holdings. All Rights Reserved.